Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marie C. Bradley
Observed names:
Bradley, Marie C.,
Marie C. Bradley
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
Aetion (United States)
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
Aetion (United States)
ORCID:
0000-0002-3231-9951
Observed ORCID:
0000-0002-3231-9951
OpenAlex ID:
A5103106696
Evaluating the Impact of Data Standardization on Real‐World Data
2025
·
Elizabeth M. Garry
, Aidan Baglivo
, et al.
·
Pharmacoepidemiology and Drug Safety
·
5
Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH Insulins
2020
·
Marie C. Bradley
, Yoganand Chillarige
, et al.
·
Diabetes Care
·
5
Exposure to Valsartan Products Containing Nitrosamine Impurities in the U nited States, Canada, and Denmark
2024
·
Efe Eworuke
, Mayura U. Shinde
, et al.
·
Pharmacoepidemiology and Drug Safety
·
4
PDF
A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions
2022
·
Christine Y. Lu
, Laura Hou
, et al.
·
Pharmacoepidemiology and Drug Safety
·
4
Illustrating an Adaptive Prespecification Framework for Observational Research: Target Trial Emulations Comparing Immunomodulator Treatments for COVID-19
2025
·
Andrew R. Weckstein
, Vera Frajzyngier
, et al.
·
Epidemiology
·
1
PDF
Insights from predicting results of the GRADE trial using real‐world data
2025
·
Sushama Kattinakere Sreedhara
, Sebastian Schneeweiss
, et al.
·
Diabetes Obesity and Metabolism
Author response for "Insights from predicting results of the GRADE trial using real-world data"
2025
·
Kattinakere Sreedhara, Sushama
, Schneeweiss, Sebastian
, et al.
·
Publons reviews and discussion
Characterization of SARS ‐ CoV ‐2 Diagnostic Tests and Liver Function Tests Among Patients With COVID ‐19 Diagnosed in Outpatient Settings Using Administrative Healthcare Data and Data From Commercial Laboratories
2025
·
Ayad K. Ali
, Aidan Baglivo
, et al.
·
Pharmacoepidemiology and Drug Safety
Dexamethasone Dose for COVID ‐19 in a Large U.S. Hospital Network From April 2020 to May 2023
2024
·
Marie C. Bradley
, Ashish Rai
, et al.
·
Pharmacoepidemiology and Drug Safety
Show more works
View as search
Works count:
9
Citation count:
19
H-index:
4
I10-index:
Year
Topic
Type